2026 · 2nd Quarter (Apr 1 - June 30)

GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS

Filed by HOOPER, LUNDY & BOOKMAN, P.C..

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 20, 2026
Income: $10,000.00
Expenses: Not reported
Registrant: HOOPER, LUNDY & BOOKMAN, P.C.
Client: GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS
Filing UUID: b03f43b6-f50d-4da5-a20a-85e0d7bcf710
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

HCR: S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools; Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37).

Literal federal measure citations: S. 2355

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.